Pricing
Login
Home
Charts
Search
Watchlist
Products

Hikal Ltd

HIKAL
₹220.76-0.59%20 Nov 2026
Reports
Pharma CRAMS

Hikal Ltd

HIKAL
₹220.76
-0.59%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹2,722Cr
Close
Close Price
₹220.76
Industry
Industry
Pharma CRAMS
PE
Price To Earnings
—
PS
Price To Sales
1.47
Revenue
Revenue
₹1,851Cr
Rev Gr TTM
Revenue Growth TTM
8.93%
PAT Gr TTM
PAT Growth TTM
-149.50%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
448514407453448552380319494519403434
Growth YoY
Revenue Growth YoY%
-17.2-5.74.84.10.07.5-6.5-29.710.4-6.05.936.3
Expenses
ExpensesCr
383420349378376429355311412414366389
Operating Profit
Operating ProfitCr
6594587572123257831053745
OPM
OPM%
14.518.414.316.516.122.36.62.316.720.39.210.3
Other Income
Other IncomeCr
01104112-35-41112
Interest Expense
Interest ExpenseCr
141520191918171516151513
Depreciation
DepreciationCr
293232323338394141424342
PBT
PBTCr
22477252468-30-47-98-10-9
Tax
TaxCr
61327718-8-12-3-6-3-2
PAT
PATCr
16345181750-22-35-614-7-6
Growth YoY
PAT Growth YoY%
-39.0-5.8-26.145.66.848.1-539.2-290.7-134.3-71.367.082.5
NPM
NPM%
3.66.61.34.03.89.1-5.9-11.0-1.22.8-1.8-1.4
EPS
EPS₹
1.32.80.41.51.44.1-1.8-2.8-0.51.2-0.6-0.5
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
448514407453448552380319494519403434
Growth YoY
Revenue Growth YoY%
-17.2-5.74.84.10.07.5-6.5-29.710.4-6.05.936.3
Expenses
ExpensesCr
383420349378376429355311412414366389
Operating Profit
Operating ProfitCr
6594587572123257831053745
OPM
OPM%
14.518.414.316.516.122.36.62.316.720.39.210.3
Other Income
Other IncomeCr
01104112-35-41112
Interest Expense
Interest ExpenseCr
141520191918171516151513
Depreciation
DepreciationCr
293232323338394141424342
PBT
PBTCr
22477252468-30-47-98-10-9
Tax
TaxCr
61327718-8-12-3-6-3-2
PAT
PATCr
16345181750-22-35-614-7-6
Growth YoY
PAT Growth YoY%
-39.0-5.8-26.145.66.848.1-539.2-290.7-134.3-71.367.082.5
NPM
NPM%
3.66.61.34.03.89.1-5.9-11.0-1.22.8-1.8-1.4
EPS
EPS₹
1.32.80.41.51.44.1-1.8-2.8-0.51.2-0.6-0.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
9261,0141,2961,5901,5071,7201,9432,0231,7851,8601,7131,851
Growth
Revenue Growth%
6.29.527.822.6-5.214.112.94.1-11.84.2-7.98.9
Expenses
ExpensesCr
7458151,0541,2911,2341,3981,6021,7661,5181,5311,4921,581
Operating Profit
Operating ProfitCr
181198242298273323341257267328220270
OPM
OPM%
19.519.618.618.818.118.817.512.715.017.712.914.6
Other Income
Other IncomeCr
2-142-1255535-73-63
Interest Expense
Interest ExpenseCr
624849585236314856756258
Depreciation
DepreciationCr
67698693828596109118134164168
PBT
PBTCr
538011114912720621910596124-78-19
Tax
TaxCr
12133446427358272633-30-14
PAT
PATCr
41687710384133161787091-49-5
Growth
PAT Growth%
2.064.414.133.5-18.157.720.6-51.2-11.230.5-153.7-149.5
NPM
NPM%
4.56.76.06.55.67.78.33.93.94.9-2.9-0.3
EPS
EPS₹
3.35.56.38.46.810.813.06.45.67.4-4.0-0.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
9261,0141,2961,5901,5071,7201,9432,0231,7851,8601,7131,851
Growth
Revenue Growth%
6.29.527.822.6-5.214.112.94.1-11.84.2-7.98.9
Expenses
ExpensesCr
7458151,0541,2911,2341,3981,6021,7661,5181,5311,4921,581
Operating Profit
Operating ProfitCr
181198242298273323341257267328220270
OPM
OPM%
19.519.618.618.818.118.817.512.715.017.712.914.6
Other Income
Other IncomeCr
2-142-1255535-73-63
Interest Expense
Interest ExpenseCr
624849585236314856756258
Depreciation
DepreciationCr
67698693828596109118134164168
PBT
PBTCr
538011114912720621910596124-78-19
Tax
TaxCr
12133446427358272633-30-14
PAT
PATCr
41687710384133161787091-49-5
Growth
PAT Growth%
2.064.414.133.5-18.157.720.6-51.2-11.230.5-153.7-149.5
NPM
NPM%
4.56.76.06.55.67.78.33.93.94.9-2.9-0.3
EPS
EPS₹
3.35.56.38.46.810.813.06.45.67.4-4.0-0.4
Sales CAGR
1 Year-8%
3 Years-5%
5 Years0%
TTM9%
EBITDA CAGR
1 Year-33%
3 Years-5%
5 Years-7%
TTM19%
Avg. ROCE
1 Year-1%
3 Years6%
5 Years8%
TTM2%
CFO / EBITDA
1 Year137%
3 Years94%
5 Years98%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
161616252525252525252525
Reserves
ReservesCr
5475896537327929091,0431,1091,1631,2381,1741,157
Current Liabilities
Current LiabilitiesCr
374440560603596657769662757790679737
Non Current Liabilities
Non Current LiabilitiesCr
337334312327355323376590543477488423
Total Liabilities
Total LiabilitiesCr
1,2751,3791,5421,6861,7681,9132,2132,3852,4872,5292,3652,341
Current Assets
Current AssetsCr
467577690830775879964939967995884870
Non Current Assets
Non Current AssetsCr
8088038528559931,0351,2491,4461,5211,5341,4811,471
Total Assets
Total AssetsCr
1,2751,3791,5421,6861,7681,9132,2132,3852,4872,5292,3652,341
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
161616252525252525252525
Reserves
ReservesCr
5475896537327929091,0431,1091,1631,2381,1741,157
Current Liabilities
Current LiabilitiesCr
374440560603596657769662757790679737
Non Current Liabilities
Non Current LiabilitiesCr
337334312327355323376590543477488423
Total Liabilities
Total LiabilitiesCr
1,2751,3791,5421,6861,7681,9132,2132,3852,4872,5292,3652,341
Current Assets
Current AssetsCr
467577690830775879964939967995884870
Non Current Assets
Non Current AssetsCr
8088038528559931,0351,2491,4461,5211,5341,4811,471
Total Assets
Total AssetsCr
1,2751,3791,5421,6861,7681,9132,2132,3852,4872,5292,3652,341

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
186163139186285229294315187280302
Investing Cash Flow
Investing Cash FlowCr
-64-102-110-125-164-156-284-292-174-137-145
Financing Cash Flow
Financing Cash FlowCr
-124-63-25-55-101-97-6-8-27-144-160
Net Cash Flow
Net Cash FlowCr
-2-24620-24415-140-3
Free Cash Flow
Free Cash FlowCr
127583357127712113-17144154
CFO To PAT
CFO To PAT%
450.5241.4179.8180.1337.4172.0183.0402.3268.3308.8-618.9
CFO To EBITDA
CFO To EBITDA%
102.682.457.462.3104.370.986.3122.769.985.4137.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
186163139186285229294315187280302
Investing Cash Flow
Investing Cash FlowCr
-64-102-110-125-164-156-284-292-174-137-145
Financing Cash Flow
Financing Cash FlowCr
-124-63-25-55-101-97-6-8-27-144-160
Net Cash Flow
Net Cash FlowCr
-2-24620-24415-140-3
Free Cash Flow
Free Cash FlowCr
127583357127712113-17144154
CFO To PAT
CFO To PAT%
450.5241.4179.8180.1337.4172.0183.0402.3268.3308.8-618.9
CFO To EBITDA
CFO To EBITDA%
102.682.457.462.3104.370.986.3122.769.985.4137.0

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
9631,7491,6892,1578631,7694,9623,4763,2654,9331,8132,722
Price To Earnings
Price To Earnings
24.425.821.920.910.213.330.944.347.054.4
Price To Sales
Price To Sales
1.01.71.31.40.61.02.51.71.82.61.11.5
Price To Book
Price To Book
2.12.92.52.91.11.94.73.12.83.91.52.3
EV To EBITDA
EV To EBITDA
7.811.59.39.15.07.016.416.215.217.311.312.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
37.237.133.433.233.633.334.030.336.638.337.937.9
OPM
OPM%
19.519.618.618.818.118.817.512.715.017.712.914.6
NPM
NPM%
4.56.76.06.55.67.78.33.93.94.9-2.9-0.3
ROCE
ROCE%
11.211.112.915.313.016.814.38.27.69.8-0.92.1
ROE
ROE%
7.311.211.513.610.314.315.06.95.97.2-4.1-0.4
ROA
ROA%
3.24.95.06.14.87.07.33.32.83.6-2.1-0.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
9631,7491,6892,1578631,7694,9623,4763,2654,9331,8132,722
Price To Earnings
Price To Earnings
24.425.821.920.910.213.330.944.347.054.4
Price To Sales
Price To Sales
1.01.71.31.40.61.02.51.71.82.61.11.5
Price To Book
Price To Book
2.12.92.52.91.11.94.73.12.83.91.52.3
EV To EBITDA
EV To EBITDA
7.811.59.39.15.07.016.416.215.217.311.312.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
37.237.133.433.233.633.334.030.336.638.337.937.9
OPM
OPM%
19.519.618.618.818.118.817.512.715.017.712.914.6
NPM
NPM%
4.56.76.06.55.67.78.33.93.94.9-2.9-0.3
ROCE
ROCE%
11.211.112.915.313.016.814.38.27.69.8-0.92.1
ROE
ROE%
7.311.211.513.610.314.315.06.95.97.2-4.1-0.4
ROA
ROA%
3.24.95.06.14.87.07.33.32.83.6-2.1-0.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr18,2349,7975,5952,7221,9841,812230
Close PriceClose₹451.70517.60977.80220.76961.25115.57207.00
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE97.5632.3533.5630.4117.54
Price To SalesPS5.188.943.001.472.190.662.28
RevenueRevenueCr3,5221,0961,8651,8519042,756101
Revenue Growth TTMRev Gr TTM%-6.0%-7.0%36.8%8.9%19.0%-0.1%22.3%
PAT Growth TTMPAT Gr TTM%-60.3%-19.0%34.0%-149.5%8.9%-184.9%44.5%
Market CapitalizationMkt CapCr18,2349,7975,5952,7221,9841,812230
Close PriceClose₹451.70517.60977.80220.76961.25115.57207.00
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE97.5632.3533.5630.4117.54
Price To SalesPS5.188.943.001.472.190.662.28
RevenueRevenueCr3,5221,0961,8651,8519042,756101
Revenue Growth TTMRev Gr TTM%-6.0%-7.0%36.8%8.9%19.0%-0.1%22.3%
PAT Growth TTMPAT Gr TTM%-60.3%-19.0%34.0%-149.5%8.9%-184.9%44.5%
Interviews